Out of Stock
Full Description
Rybelsus is an FDA-approved prescription medication for adults with type 2 diabetes mellitus. As the first oral GLP-1 receptor agonist, it mimics natural hormones to stimulate insulin release, regulate glucose levels, and slow digestion—helping to manage blood sugar effectively.
Clinical studies have shown that patients on the highest dose (14 mg) experienced improved blood sugar control and an average weight loss of 4.4 kg over 52 weeks.
Rybelsus is intended to be used alongside diet and exercise to improve glycemic control in patients with type 2 diabetes.
In this plan
Features
Directions
Learn More (Clinical studies)
Select your medication.
Pick the treatment plan you want. Our Doctors recommend the longer plans for new users and best results.
Speak to a Doctor via online video consultation.
Receive medication.
Ongoing care and support.
OVA’s weight loss plans are co-designed with Dr. Ben Ng, Singapore’s leading endocrinologist and Chief Medical Officer at OVA. A senior consultant with over 20 years of clinical experience, Dr. Ng is renowned for his expertise in diagnosing and treating obesity, diabetes, thyroid disorders, and a broad spectrum of metabolic and endocrine conditions.